Upregulation of ITGAM and CD86 following LSD1 inhibition was correlated with myeloid differentiation, inhibition of human monocytic leukemia cell proliferation [48], and sensitization of AML cells to all-trans-retinoic acid [49]. Here, CD86 is linked to monocytic leukemia.